It is clear that we are all going to have to work harder--both the government and the private sector--in making AIDS medications available to those who need them. It is one of the modern paradoxes that the new AIDS drugs can defer an HIV infected individual's progression to disability. Yet, it may only be that the individual can get financial assistance when disabled, a situation we would clearly like to prevent. I am aware of a Pharmaceutical Research and Manufacturers of America study which indicated that, as of December 1, there were 122 medicines in testing for AIDS. The cost, which the Senator alluded to, is astounding. One company spent more than $1 billion over a 10-year period to develop a protease inhibitor. American technological gains are nothing short than miraculous, but we all have to recognize they are expensive as well. I am heartened by the Senator's remarks about funding for the State ADAP programs.
Orrin Hatch: “It is clear that we are all going to have to work harder--both the government and the private sector--in making AIDS…”
Editor's note · Context
Discussing the need for improved access to AIDS medications and funding for related programs.
Share
More from Orrin Hatch
nearly 3 months ago, I came to the Senate floor for the first time to support President Trump's nomination of Brett Kavanaugh to the U.S. Supreme Court. Here is what I had to say at that time: Judge Kavanaugh is among the most…
It is important to support the ability of retirement plans to honor commitments made to working Americans.
I want to thank my dear colleague from Iowa. He is one of the greatest Senators I have served with. He is just a wonderful friend and a wonderful Senator. He has worked his tail off the whole time he has been here. I am grateful for his…
Our trade policy should strengthen our relationships with our allies while targeting China's most harmful trade practices.





